Skip to content
Biotechnology

AusBiotech celebrates 40 years of advocacy and industry leadership

AusBiotech 2 mins read

10 September 2026

 

AusBiotech, the peak industry body for life sciences, is celebrating its 40-year anniversary.

 

The special milestone was recognised at an event in Parliament House Canberra on Monday among Ministers, parliamentarians and a cross section of members comprising leading medical science innovators, entrepreneurs, and investors.

 

Guests included Industry and Innovation Minister Tim Ayres, Health and Ageing Minister Mark Butler, Assistant Minister for Science, Technology and the Digital Economy Andrew Chartlon, Shadow Minister for Science, Technology and Innovation Aaron Violi, House Speaker Milton Dick and several cross-party MPs, Senators and 60 AusBiotech members.

 

AusBiotech CEO Rebekah Cassidy said the important anniversary reflects the industry’s continued growth and success.

 

From humble beginnings with fewer than 100 members in the 1980s, AusBiotech has grown to be a thriving, well-connected community of more than 3,500 members,” Ms Cassidy said.

 

“Our industry is a major economic contributor, accounting for more than 350,000 jobs across Australia, and has doubled in size since 2017. Cumulatively, since 2016, the biotech industry has been our greatest value-add export industry outside of primary industries, making it key to Australia’s diversified economy.

 

The event was a wonderful opportunity to promote the importance of the biotech, health tech and medtech industry to our nation's health and economy.

 

“It also served as a poignant reminder of the need for the government and industry to continue working closely together, to ensure our vibrant industry remains strong.

 

“We are very grateful to our thousands of members who work tirelessly in the pursuit of scientific excellence. Our membership is diverse but united in its dedication and commitment to saving lives and improving patient outcomes.

 

“I also thank the AusBiotech Board, including our Chair Dr James Campbell, for its leadership and vision.

 

“We sincerely thank all those who attended and shared this special occasion with us.

 

“We look forward to celebrating this milestone further, with more of our members and the wider sector, at a major 40th Anniversary Gala Dinner, to be held in October during Australia’s Biggest Week in Biotech.”

ENDS

Media: William Sparling [email protected] 0416 628 276

 

About AusBiotech

AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3500 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members’ growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies. 

More from this category

  • Biotechnology, Business Company News
  • 09/09/2026
  • 13:13
JMM

How AI Is reshaping prenatal care and fertility treatment in Australia

The testing journey of pregnancy is changing. From routine ultrasounds to AI-assisted embryo selection, a new wave of technology is targeting one of the…

  • Contains:
  • Biotechnology, Research Development
  • 01/09/2026
  • 10:15
Cartherics Pty Ltd

Cartherics and Zucker Institute execute research collaboration and option agreement to combine iPSC-derived NK cell platform with novel anti-tissue factor antibody

Melbourne, Australia, 1 September 2026 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology companydeveloping off-the-shelfimmunecell therapiesfocusing onhigh-impact women’s diseases, with lead programs in ovarian cancerand endometriosis,today announced that it has executed a research collaboration and option agreement with the Zucker Institute (the commercialisation entity for the Medical University of South Carolina – MUSC). Under the agreement, the parties will explore Cartherics’ iPSC-derived chimeric antigen receptor natural killer (CAR-NK) platform in combination with a novel anti-tissue factor antibody developed by researchers at MUSC and the Regina Elena National Cancer Institute for potential applications in cancer and endometriosis. Tissue factor (TF)…

  • Biotechnology, Business Company News
  • 25/08/2026
  • 14:38
Diversified Australia

Australia’s flagship security event marks 40 years as industry prepares to gather in Sydney next week.

Key Facts: Event: Security Exhibition & Conference Date and location: 2-4 September 2026, ICC Sydney Organiser: Diversified Australia Co-located with: Fire Security Expo and…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.